IP Library Granted Patent US 7,893,220
Granted Patent B2
US 7,893,220 · App. 12/170,355 · Granted Feb 22, 2011

Busulfan immunoassay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,893,220
App. No.
12/170,355
Granted
Feb 22, 2011
Kind
B2
Abstract

Novel conjugates of busulfan and novel busulfan immunogens derived from α-substituted derivatives of busulfan and antibodies generated by these busulfan linked immunogens are useful in immunoassays for the quantification and monitoring of busulfan in biological fluids.

Claims (28)

1. An antibody which binds selectively to busulfan and does not have any substantial cross-reactivity to tetramethylene sulfone, tetrahydrothiophene and tetrahydrothiophene-3-ol-1,1-dioxide.

2. The antibody of claim 1 , wherein said antibody is derived from mice, rabbits or rats.

3. The antibody of claim 1 , wherein said antibody is a monoclonal antibody.

4. The antibody of claim 2 , wherein said antibody is a monoclonal antibody.

5. The antibody of claim 1 , wherein said antibody is derived from an immunogen of a polyamine polymer with a compound selected from the group consisting of compounds of the formula:

wherein A is lower alkylene;

X′ is a functional linking group;

Y is an organic spacing group;

X is a terminal functional group capable of binding to a polyamine polymer;

p and z are independent integers of from 0 to 1;

or a compound of the formula

wherein A′ is lower alkylene or lower alkenylene;

X′, Y, X, p and z are as above

or mixtures thereof.

6. The antibody of claim 5 , wherein said antibody is derived from mice, rabbits or rats.

7. The antibody of claim 5 , wherein said antibody is a monoclonal antibody.

8. The antibody of claim 6 , wherein said antibody is a monoclonal antibody.

9. The antibody of claim 5 , wherein said compound is

wherein A, X′, Y, X, p and z are as above.

10. The antibody of claim 9 wherein said wherein X is

and R 3 is hydrogen or taken together with its attached oxygen chain forms a reactive ester.

11. The antibody of claim 10 , wherein z is 0 and p is 1.

12. The antibody of claim 11 , wherein A is —(CH 2 ) v — and v is 1 or 2.

13. The antibody of claim 12 , wherein v is 2.

14. The antibody of claim 5 , wherein said compound is

wherein A′, X′, Y, X and z are as above.

15. The antibody of claim 14 , wherein X is

and R 3 is hydrogen or taken together with its attached oxygen chain form a reactive ester.

Assignments (1)
SECURITY INTEREST Recorded Nov 17, 2015
From: SALADAX BIOMEDICAL, INC.
To: SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Reel/Frame 037126/0733 →